NCT05460195 2022-07-15Sintilimab Combined With Anlotinib for Perioperative Non-small Cell Lung Cancer Based on MRD EvaluationShanghai Chest HospitalPhase 2 Unknown42 enrolled
NCT05167604 2021-12-22Clinical Value of MRD Monitoring for Adjuvant Therapy in Postoperative NSCLCTang-Du HospitalUnknown150 enrolled
NCT05079022 2021-10-15ctDNA-MRD Based Adjuvant Targeted Therapy for EGFR Positive Stage I Lung AdenocarcinomasPeking University People's HospitalPhase 1/2 Unknown50 enrolled